Advertisement
Advertisement

TERN

TERN logo

Terns Pharmaceuticals Inc

5.79
USD
-0.14
-2.36%
Dec 24, 12:59 UTC -5
Closed
...

Terns Pharmaceuticals Inc Profile

About

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY, Calif.

Info & Links

CEO

Amy Burroughs

Headquarters

1065 EAST HILLSDALE BLVD., SUITE 100
FOSTER CITY, CA 94404, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

7

Employees

66

Terns Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

491.80M

Enterprise Value

221.67M

Enterprise Value/EBITDA(ttm)

-2.13

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.13

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-32.76%

Return on Invested Capital(ttm)

-34.10%

Return on Assets(ttm)

-31.33%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-104.11M

Net Income Available to Common(ttm)

-88.07M

Diluted EPS(ttm)

-1.18

Share Statistics

Beta (5Y Monthly)

-0.36

52-Week Change

-4.61%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

84.94M

Dividend Yield

0.00%

Float4

72.11M

% Held by Insiders

15.10%

% Held by Institutions

98.26%

Balance Sheet

Total Cash(mrq)

372.78M

Total Cash Per Share(mrq)

4.39

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

32.99%

Quick Ratio(mrq)

32.99%

Book Value Per Share(mrq)

4.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.71

Free Cash Flow(ytd)

-55.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement